KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Return on Assets (2021 - 2024)

AbCellera Biologics (ABCL) has disclosed Return on Assets for 4 consecutive years, with 0.03% as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Return on Assets rose 5.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Sep 2024, up 5.0%, and an annual FY2024 reading of 0.11%, down 2.0% over the prior year.
  • Return on Assets was 0.03% for Q3 2024 at AbCellera Biologics, up from 0.05% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.26% in Q1 2021 and bottomed at 0.1% in Q4 2023.
  • Average Return on Assets over 4 years is 0.06%, with a median of 0.1% recorded in 2022.
  • The sharpest move saw Return on Assets decreased -24bps in 2023, then increased 5bps in 2024.
  • Year by year, Return on Assets stood at 0.12% in 2021, then decreased by -17bps to 0.1% in 2022, then tumbled by -195bps to 0.1% in 2023, then surged by 66bps to 0.03% in 2024.
  • Business Quant data shows Return on Assets for ABCL at 0.03% in Q3 2024, 0.05% in Q2 2024, and 0.07% in Q1 2024.